Daejeon, South Korea

Hyoung Jin Kim

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Hyoung Jin Kim: Innovator in Pharmaceutical Compounds

Introduction

Hyoung Jin Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work primarily focuses on compounds that address various medical conditions, particularly those related to necrosis and oxidative stress.

Latest Patents

Among his latest patents, Hyoung Jin Kim has developed an indole compound that serves as an inhibitor of necrosis. This application relates to a compound represented by a specific formula, which can be used in a composition for the prevention or treatment of necrosis and associated diseases. Additionally, he has created a pharmaceutical composition that includes this indole compound, aimed at treating diseases linked to oxidative stress, mitochondrial dysfunction, and ischemic reperfusion injury. His innovations also extend to cosmetic compositions that utilize the antioxidant properties of indole compounds.

Career Highlights

Hyoung Jin Kim has worked with notable companies such as LG Life Sciences and LG Chem. His experience in these organizations has allowed him to advance his research and development in pharmaceutical sciences, contributing to the creation of effective medical treatments.

Collaborations

He has collaborated with esteemed colleagues, including Soon Ha Kim and Heui Sul Park, to further enhance his research efforts and innovations in the pharmaceutical field.

Conclusion

Hyoung Jin Kim's contributions to the development of pharmaceutical compounds highlight his role as a key innovator in the industry. His patents reflect a commitment to addressing critical health issues through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…